ALS Clinical Trials & Drug Development Liaison

The ALS Therapy Development Institute (ALS TDI) is a leading non‑profit biotechnology company dedicated to discovering and advancing effective treatments for amyotrophic lateral sclerosis (ALS). At ALS TDI, we are driven by our mission to find therapies that can make a real difference for patients living with ALS.

We are seeking a highly knowledgeable and mission‑driven professional to survey and synthesize the ALS clinical trial landscape, engage directly with drug sponsors, and translate complex scientific information for internal teams, patients facing ALS, and the broader ALS community. This role serves as a critical bridge between drug developers, researchers, patients, and internal stakeholders, ensuring that information around ALS clinical trials remains accurate, current, and accessible.

• Continuously monitor and evaluate the global ALS clinical trial and drug development landscape, focusing on clinical and late stage pre‑clinical programs.
• Track trial designs, endpoints, enrollment criteria, timelines, and outcomes.
• Identify trends, gaps, and emerging therapeutic approaches relevant to ALS.

• Conference regularly with pharmaceutical and biotechnology sponsors, academic investigators, and clinical research programs.
• Develop and maintain professional relationships to support information exchange and collaboration.
• Represent the organization in meetings, briefings, and conferences related to ALS drug development.

• Educate internal teams on ALS clinical trials, therapeutic mechanisms, and regulatory developments.
• Translate technical and scientific information into clear, accurate, and accessible content for the ALS community, including patients, caregivers, and advocates.
• Take part in virtual meetings with families facing clinical trial decisions.
• Support presentations, briefings, webinars, and written materials tailored to diverse audiences.

• Monitor and review the ALS Trial Navigator to ensure accuracy, completeness, and timeliness.
• Collaborate with digital, communications, and scientific teams to maintain high‑quality, trusted resources.

• Prepare summaries, landscape reports, and briefing documents for leadership and the ALS TDI Development Team.
• Maintain organized records of sponsor interactions, trial updates, and key insights.

• Strong understanding of clinical trial design and drug development, preferably in neurodegenerative diseases or ALS.
• Demonstrated ability to communicate complex scientific information clearly to both technical and lay audiences.
• Experience engaging with external stakeholders such as biotech/pharma sponsors or academic researchers.
• Ability to convey empathy and warmth in conversations with patient community.

• Direct experience with ALS research, clinical trials, or patient advocacy.
• Familiarity with regulatory pathways (FDA, EMA) and trial registries (e.g., Clinical Trials.gov).

ALS‑TDI is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.